TBT
CRL icon

Texas Bank & Trust’s Charles River Laboratories CRL Stock Holding History

Texas Bank & Trust’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,600
Closed -$319K – 179
2025
Q4 		$319K Hold
1,600
– – 0.12% 144
2025
Q3 		$250K Hold
1,600
– – 0.09% 163
2025
Q2 		$243K Hold
1,600
– – 0.1% 166
2025
Q1 		$241K Hold
1,600
– – 0.1% 161
2024
Q4 		$295K Buy
+1,600
New +$308K 0.12% 147

Other funds holding CRL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Texas Bank & Trust's CRL Position: Q1 2026 in Review

Texas Bank & Trust sold out of Charles River Laboratories (CRL) in Q1 2026, closing a stake of 1,600 shares — an estimated $319K sold.

Texas Bank & Trust first reported a position in CRL in Q4 2024 and held it in 5 quarters. The position peaked at $319K in Q4 2025. 560 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Texas Bank & Trust reported no remaining Charles River Laboratories position as of Q1 2026 after selling out during the quarter.
  • Texas Bank & Trust sold 1,600 Charles River Laboratories shares in Q1 2026, an estimated $319K.
  • Texas Bank & Trust first reported a position in Charles River Laboratories in Q4 2024 and held it in 5 quarters.
  • Texas Bank & Trust's Charles River Laboratories position peaked at $319K in Q4 2025.
  • 560 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Texas Bank & Trust's 13F filing for Q1 2026, filed 30 Apr 2026.